While the market searches for "abstract" rejuvenation methods, we operate with a patent-proven foundation. The world is investing in longevity trends, but biological system stability and prolonged youth require real, measurable evidence. Our flagship product, BiomEnforcer® (Patent No. 141234, granted on 25 March 2020) , officially secures this breakthrough. Even during baseline studies, the Molecularly Structured Protein Matrix (MSPM) technology proved its capacity to completely overcome metabolic decline, even in senescent cohorts under conditions of critical stress and deficiency. The results are remarkable: the protocol ensures the restoration of reproductive parameters to peak values and activates cellular-level regeneration. This is a verified bio-digital technology and the foundation of the modern OMARIDIN framework, backed by an official patent and scientific practice. Full evidentiary information and a detailed report are openly available: Zenodo Record 20377526 . #...

  How Exclusive Is the Weight-Control Method Described in the Article Cybernetic Regulation of Body Mass: Overcoming the Limitations of Restrictive Dieting Through the MSPM–NASP Framework ? https://doi.org/10.5281/zenodo.20455572   This method is absolutely exclusive (unique on the global market) at the intersection of three key factors. While separate studies of the gut or sound exist worldwide, the specific architecture presented in Cybernetic Regulation of Body Mass: Overcoming the Limitations of Restrictive Dieting Through the MSPM–NASP Framework has no equivalent.

At the cellular level, ageing is strongly associated with impaired mitochondrial bioenergetics, reduced NAD ⁺ availability, and disruptions in proteostasis. These processes are not independent; they are dynamically regulated within a broader physiological network. https://pmtstructure.com   The use of a Saccharomyces-derived matrix is grounded in the evolutionary conservation of core eukaryotic metabolic pathways, suggesting that structurally preserved biochemical inputs may interact with human cellular systems at the level of fundamental metabolic regulation. https://zenodo.org/records/19534062

We are proud to announce that our application (CAT3-0000000593) has been officially  submitted to The Catalyst Program by the Translational Research Institute for Space Health  (TRISH). This milestone reflects Patented MT’s commitment to integrating advanced structural innovations into the world’s most high-tech industries. Our collaboration with TRISH opens  doors for breakthroughs aimed at ensuring human health and safety in space—an  environment where precision and structural integrity are paramount. Onward to new discoveries at the intersection of deep tech and space exploration. Learn more about Patented MT: https://pmtstructure.com  

Research results confirm that OMARIDIN™ is a universal tool for protein metabolism correction and immune system enhancement. Application experience in Ukraine (via EKO 777 ltd ) and advanced manufacturing in Lithuania ( Patented MT https://pmtstructure.com ) guarantee stability and high scientific value in the global market.

Biology is regulated not only by molecules, but by structure. We investigate how organised protein matrices interact with human physiology and adaptive stability. A research and development initiative focused on structural biological interaction and its practical application in precision nutrition and healthy ageing. https://pmtstructure.com  

  Molecularly Structured Protein Matrix (MSPM) We are pleased to confirm that the theoretical framework and clinical rationale for the MSPM and NASP technologies have now been formally registered within Zenodo (CERN) international research repository. This publication secures the priority of our intellectual property regarding metabolic correction and provides stakeholders with independent verification of the project’s scientific rigour. https://pmtstructure.com   The full technical report can be accessed via the following  https://zenodo.org/records/19563962